Background: Serum concentration of procollagen type I carboxy-terminal propeptide (PICP)
is proved to be a good marker for myocardial fibrosis in hypertension. Adiponectin is a …

Background: Serum concentration of procollagen type I carboxy-terminal propeptide (PICP)
is proved to be a good marker for myocardial fibrosis in hypertension. Adiponectin is a …

Objective. The serum concentration of procollagen type I carboxyterminal propeptide (PICP)
is a good marker for collagen deposition in hypertension. Increased collagen deposition was …

BACKGROUND: Recent studies suggest that adiposity is associated with arterial stiffness.
However, it is unclear which adipokine or what adiposity related parameters are related with …

We evaluated novel and traditional biomarkers as well as hemodynamic parameters
associated with the development of left ventricular hypertrophy (LVH) in nondiabetic patients …

Background Adiponectin has been implicated in metabolic syndrome (MetS) and arterial
stiffness (AS). We aim to determine the relationship between serum adiponectin …

Objective: To explore the expression levels of serum adiponectin (APN) and inflammatory
cytokines in hypertension patients and the correlation of levels of APN and inflammatory …

Purpose Plasma adiponectin concentrations are inversely related with metabolic syndrome
(MetS), and MetS is associated with increased risk for heart failure (HF). However, the …

Objective To observe serum adiponectin, free fatty acid (FFA) profile and other glucose and
lipid metabolic parameters in essential hypertensive patients with metabolic syndrome …

Background: Adiponectin is an adipokine with anti-inflammatory, anti-atherogenic properties
and related to metabolic syndrome (MetS). The relationship between adiponectin and …